Tempe R&D Tax Credit: Boosting Innovation Opportunities

R&D Tax Credits for Tempe, Arizona Businesses

Tempe, Arizona, is known for its strong presence in technology, education, healthcare, and aerospace sectors. Top companies in the city include Arizona State University, a leading educational and research institution; State Farm, a major insurance company; Banner Health, a prominent healthcare provider; US Airways, a key player in the aerospace industry; and Insight Enterprises, a global technology solutions provider. The R&D Tax Credit can benefit these industries by lowering tax burdens, encouraging innovation, and improving business performance.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 3104 E Camelback Road, Phoenix, Arizona is less than 12 miles away from Tempe and provides R&D tax credit consulting and advisory services to Tempe and the surrounding areas such as: Phoenix, Mesa, Chandler, Gilbert and Glendale.

If you have any questions or need further assistance, please call or email our local Arizona Partner on (520) 336-9423.
Feel free to book a quick teleconference with one of our Arizona R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Tempe, Arizona Patent of the Year – 2024/2025

NOCIRA LLC has been awarded the 2024/2025 Patent of the Year for its innovative approach to non-invasive migraine treatment. Their invention, detailed in U.S. Patent No. 11859606, titled ‘Magnetically driven pressure generator’, utilizes a magnetically driven pressure generator to deliver precise air pulses into the ear canal.

This device features a housing, a flexible membrane, and two magnetic force generators. By oscillating the membrane, it alters the chamber’s volume, thereby modulating pressure. The controlled air pulses are designed to stimulate pressure-sensitive neurons in the ear, aiming to reset pain pathways in the brain.

Unlike traditional migraine treatments that rely on medication, Nocira’s technology offers a drug-free alternative. The device’s precise control over air pressure allows for personalized therapy, potentially reducing side effects associated with pharmaceuticals.

Nocira’s commitment to innovation is evident in its expanding patent portfolio, which includes recent grants in the United States, Europe, and Japan. These patents focus on personalizing migraine treatments based on individual symptoms, highlighting the company’s dedication to adaptive healthcare solutions.

With this patented technology, Nocira aims to transform migraine management, offering patients a non-invasive, personalized, and effective treatment option.